Generic placeholder image

Current Computer-Aided Drug Design

Editor-in-Chief

ISSN (Print): 1573-4099
ISSN (Online): 1875-6697

Research Article

Multi-objective Genetic Algorithm for De Novo Drug Design (MoGADdrug)

Author(s): R. Vasundhara Devi*, S. Siva Sathya and Mohane S. Coumar

Volume 17, Issue 3, 2021

Published on: 20 June, 2020

Page: [445 - 457] Pages: 13

DOI: 10.2174/1573409916666200620194143

Price: $65

Abstract

Background: A multi-objective genetic algorithm for De novo drug design (MoGADdrug) has been proposed in this paper for the design of novel drug-like molecules similar to some reference molecules. The algorithm developed accepts a set of fragments extracted from approved drugs and available in fragment libraries and combines them according to specified rules to discover new drugs through the in-silico method.

Methods: For this process, a genetic algorithm has been used, which encodes the fragments as genes of variable length chromosomes and applies various genetic operators throughout the generations. A weighted sum approach is used to simultaneously optimize the structural similarity of the new drug to a reference molecule as well as its drug-likeness property.

Results: Five reference molecules namely Lidocaine, Furano-pyrimidine derivative, Imatinib, Atorvastatin and Glipizide have been chosen for the performance evaluation of the algorithm.

Conclusion: Also, the newly designed molecules were analyzed using ZINC, PubChem databases and docking investigations.

Keywords: De novo drug design, drug-likeness, genetic algorithm, multi-objective optimization, oral bio-availability, tanimoto similarity.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy